We are live on ! Find out more
BSX icon

Boston Scientific

888 hedge funds and large institutions have $54.6B invested in Boston Scientific in 2021 Q4 according to their latest regulatory filings, with 121 funds opening new positions, 290 increasing their positions, 322 reducing their positions, and 95 closing their positions.

New
Increased
Maintained
Reduced
Closed

27% more first-time investments, than exits

New positions opened: 121 | Existing positions closed: 95

1% more funds holding

Funds holding: 877888 (+11)

3% less capital invested

Capital invested by funds: $56.3B → $54.6B (-$1.66B)

10% less repeat investments, than reductions

Existing positions increased: 290 | Existing positions reduced: 322

1.09% less ownership

Funds ownership: 91.5%90.41% (-1.1%)

18% less funds holding in top 10

Funds holding in top 10: 119 (-2)

42% less call options, than puts

Call options by funds: $271M | Put options by funds: $467M

Holders
888
Holders Change
+11
Holders Change %
+1.25%
% of All Funds
13.67%
Holding in Top 10
9
Holding in Top 10 Change
-2
Holding in Top 10 Change %
-18.18%
% of All Funds
0.14%
New
121
Increased
290
Reduced
322
Closed
95
Calls
$271M
Puts
$467M
Net Calls
-$196M
Net Calls Change
-$17.7M
Name Holding Trade Value Shares
Change
Change in
Stake
LWAM
451
Legacy Wealth Asset Management
Minnesota
$883K +$91.7K +2,183 +12%
AWM
452
Apollon Wealth Management
South Carolina
$873K +$368K +8,747 +74%
EH
453
Equitable Holdings
New York
$867K -$166K -3,961 -16%
CA
454
Cullinan Associates
Kentucky
$867K +$630K +15,000 +278%
KWMG
455
King Wealth Management Group
Florida
$852K -$378K -9,000 -31%
CCM
456
Community Capital Management
Florida
$850K +$252K +6,000 +43%
SFI
457
Siemens Fonds Invest
Germany
$848K +$9.88K +235 +1%
WAM
458
Wolverine Asset Management
Illinois
$845K +$836K +19,893 New
BOM
459
Bank of Marin
California
$841K +$5.67K +135 +0.7%
SI
460
Stephens Inc
Arkansas
$824K +$191K +4,540 +31%
Fuller & Thaler Asset Management
461
Fuller & Thaler Asset Management
California
$822K -$118K -2,800 -13%
VIA
462
Vident Investment Advisory
Georgia
$821K -$678K -16,132 -46%
AIP
463
Ameritas Investment Partners
Nebraska
$794K -$21.9K -521 -3%
MYAM
464
Meiji Yasuda Asset Management
Japan
$787K +$73.5K +1,748 +10%
RJT
465
Raymond James Trust
Florida
$781K -$68.4K -1,628 -8%
Qube Research & Technologies (QRT)
466
Qube Research & Technologies (QRT)
United Kingdom
$774K -$3.86M -91,811 -83%
FHA
467
Flagship Harbor Advisors
Massachusetts
$773K -$4.2K -100 -0.5%
CNC
468
Canandaigua National Corp
New York
$758K -$10.1K -240 -1%
AFG
469
Allegheny Financial Group
Pennsylvania
$754K
BLAM
470
Bourne Lent Asset Management
New York
$753K
OSAM
471
O'Shaughnessy Asset Management
Connecticut
$751K -$126K -2,988 -14%
VI
472
Vestcor Inc
New Brunswick, Canada
$747K -$142K -3,369 -16%
AIM
473
Achmea Investment Management
Netherlands
$730K
AIMCA
474
Alberta Investment Management Corp (AIMCo)
Alberta, Canada
$726K -$8.52M -202,700 -92%
WI
475
Wahed Invest
New York
$722K +$714K +16,997 New

BSX Hedge Fund Activity: Q4 2021 in Review

888 of the 6,498 institutional investors tracked by Wall St. Rank reported a position in Boston Scientific (BSX) for Q4 2021, worth a combined $54.6B — down 3% from $56.3B a quarter earlier.

Buyers outnumbered sellers: 121 funds opened new BSX positions and 95 closed out — a net gain of 26 holders — while 290 added to existing stakes and 322 trimmed.

The largest buyer was Viking Global Investors, adding an estimated $508M. The largest seller was Wellington Management Group, cutting an estimated $391M.

  • 888 institutional investors held Boston Scientific (BSX) as of Q4 2021, up from 877 in Q3 2021.
  • Funds reported $54.6B of Boston Scientific stock for Q4 2021, down 3% quarter-over-quarter.
  • 121 funds opened new Boston Scientific positions in Q4 2021 and 95 closed out, a net change of +26 holders.
  • The largest Boston Scientific buyer in Q4 2021 was Viking Global Investors, an estimated $508M added.
  • The largest Boston Scientific seller in Q4 2021 was Wellington Management Group, an estimated $391M sold.

Based on aggregated 13F filings for Q4 2021.